COLL COLLEGIUM PHARMACEUTICAL INC Management Changes 8-K Filing 2024 - CEO Appointment Collegium Pharmaceutical announced its financial results for Q3 2024 and appointed Vikram Karnani as CEO, with a salary of $875,000 and a $500,000 signing bonus, effective November 12, 2024.Get access to all SEC 8-K filings of the COLLEGIUM PHARMACEUTICAL INC